The environmental and health impact of simple food substitutions in the United States (U.S.) diet.
PharmaDrug’s Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – August 19, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on